European Companies Search Engine
EU funding (€1,499,498): Advanced analysis of multiparametric volumetric ultrafast ultrasound: a novel approach for non-invasive breast cancer diagnosis Hor28 Nov 2024 EU Research and Innovation programme "Horizon"
Overview
Text
Advanced analysis of multiparametric volumetric ultrafast ultrasound: a novel approach for non-invasive breast cancer diagnosis
Tumour development follows a diversity of complementary biological pathways, including the modification of the tissue structure and vascularization, which are not currently captured by imaging techniques in the clinic. Breast cancer patients undergo a series of imaging sessions using complementary modalities, including ionizing mammographies. In many cases, this imaging is not precise enough for a diagnosis, so that tissue samples in the form of biopsies are used to further characterize the tumour and determine the appropriate treatment. Beyond the pain and stress associated with biopsies, this complex process is costly and time consuming, and delays the time to diagnosis. Ultrasound B-mode imaging is largely used in the diagnostic process of breast cancer, in part because it is low cost, portable and largely available, as well as non-ionizing and non-invasive. Our laboratory, Institute Physics for Medicine Paris has recently developed several quantitative techniques allowing for the measurement of tissue stiffness, fiber organization, and vascular mapping, all relevant to tumour development. In this project, I propose a new approach to diagnosing breast cancer non-invasively by applying machine learning analysis to rich volumetric multiparametric maps of complementary tumour aspects, obtained using these innovative ultrafast ultrasound techniques. The project will tackle the technological challenge of integrating these techniques into a common acquisition and analysis framework, and include the collection of a large clinical dataset and the development and validation of a predictive malignancy model informing on tumour characteristics for the diagnosis. This approach will open the door to fully virtual biopsies, impacting society on a large scale in terms of cost, diagnostic efficacy, and patient comfort.
Funded Companies:
| Company name | Funding amount |
| Institut National de la Sante et de la Recherche Medicale | €1,499,498 |
Source: https://cordis.europa.eu/project/id/101164974
The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Institut National de la Sante et de la Recherche Medicale, Paris, France.
The visualizations for "Institut National de la Sante et de la Recherche Medicale - EU funding (€1,499,498): Advanced analysis of multiparametric volumetric ultrafast ultrasound: a novel approach for non-invasive breast cancer diagnosis"
are provided by
North Data
and may be reused under the terms of the
Creative Commons CC-BY license.
